About The TRANSPERS Center
The Center for Translational and Policy Research on Personalized Medicine (the TRANSPERS Center) at the University of California, San Francisco is a first-of-its-kind research center dedicated to developing evidence-based information for patients, providers, industry, researchers and policymakers to objectively assess how personalized medicine can be most beneficial and efficient in improving health outcomes.
The goal of the TRANSPERS Center is to advance the translational continuum for personalized medicine to ensure that new personalized medicine technologies can be used most beneficially and efficiently in clinical care. The Center will do so in part by bringing together a broad spectrum of stakeholders from academia, government and groups representing patients, providers and payers to examine the critical issues related to translating personalized medicine into practice and policy.
A major focus of the TRANSPERS Center is coverage, reimbursement, and policy decisions by payers. Since 2007, we have been working with a Reimbursement and Policy Advisory Committee comprised of private payers and thought leaders. The Advisory Committee includes senior executives from six of the seven largest US plans, leading regional plans, and pharmacy benefits management companies as well as thought leaders with industry, government, and Medicare perspectives. Our work on coverage and reimbursement policy decisions by payers has been funded by two grants from Blue Shield of California Foundation, an Aetna Foundation grant and two NIH/National Cancer Institute grants.
For more, please read our Center Summary.